suPARnostic: an advanced predictive tool for detecting recurrence in renal cell carcinoma

Abstract Background Plasma soluble urokinase-type Plasminogen Activator Receptor (suPAR) predicts disease aggressiveness in renal cell carcinoma (ccRCC), but its prognostic accuracy has not been investigated. To investigate the prognostic accuracy of preoperative plasma suPAR in patients who receive...

詳細記述

書誌詳細

出版年:	BMC Urology
主要な著者:	Nessn Azawi, Karina Sif Sondergaard Mosholt, Nathalie Demuth Fryd, Lars Lund, Juan Ignacio Brignone, Nanna Hvid, Helle Wulf-Johansson, Ole Birger Vesterager Pedersen, Susanne Gjørup Saekmose, Saeed Dabestani
フォーマット:	論文
言語:	英語
出版事項:	BMC 2023-10-01
主題:	Clear cell kidney Cancer Biomarker Liquid biopsy Prognostication Recurrence free survival
オンライン･アクセス:	https://doi.org/10.1186/s12894-023-01337-z